Tamoxifen-associated steatohepatitis--report of three cases.
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.
Pinto
H C
HC
Department of Medicine, University Hospital Santa Maria, Lisbon, Portugal.
Baptista
A
A
Camilo
M E
ME
de Costa
E B
EB
Valente
A
A
de Moura
M C
MC
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D001706:Biopsy; D001943:Breast Neoplasms / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D013629:Tamoxifen